Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · IEX Real-Time Price · USD
5.33
-0.12 (-2.20%)
At close: Apr 26, 2024, 4:00 PM
5.25
-0.08 (-1.50%)
After-hours: Apr 26, 2024, 6:37 PM EDT
Monte Rosa Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$11.00
Upside
+106.38%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Initiates $11 | Buy | Initiates | $11 | +106.38% | Feb 15, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $31 → $11 | Buy | Maintains | $31 → $11 | +106.38% | Oct 19, 2023 |
| Credit Suisse | Credit Suisse | Hold Reiterates $11 | Hold | Reiterates | $11 | +106.38% | Aug 11, 2023 |
| Credit Suisse | Credit Suisse | Hold Reiterates $11 | Hold | Reiterates | $11 | +106.38% | May 12, 2023 |
| Credit Suisse | Credit Suisse | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | +106.38% | Mar 17, 2023 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $19 | Hold → Buy | Upgrades | $19 | +256.47% | Jan 3, 2023 |
| UBS | UBS | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +312.76% | Oct 13, 2022 |
| Jefferies | Jefferies | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +275.23% | Aug 15, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $40 → $21 | Buy | Maintains | $40 → $21 | +294.00% | May 12, 2022 |
| Credit Suisse | Credit Suisse | Hold Initiates $19 | Hold | Initiates | $19 | +256.47% | Apr 28, 2022 |
| Wells Fargo | Wells Fargo | Hold Initiates $19 | Hold | Initiates | $19 | +256.47% | Feb 10, 2022 |
| SVB Leerink | SVB Leerink | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 14, 2021 |
| Piper Sandler | Piper Sandler | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jul 19, 2021 |
| JP Morgan | JP Morgan | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jul 19, 2021 |